Thomas Joos

7.2k total citations
139 papers, 4.4k citations indexed

About

Thomas Joos is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Thomas Joos has authored 139 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 40 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Spectroscopy. Recurrent topics in Thomas Joos's work include Advanced Biosensing Techniques and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Advanced Proteomics Techniques and Applications (20 papers). Thomas Joos is often cited by papers focused on Advanced Biosensing Techniques and Applications (45 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Advanced Proteomics Techniques and Applications (20 papers). Thomas Joos collaborates with scholars based in Germany, United States and Sweden. Thomas Joos's co-authors include Markus F. Templin, Dieter Stoll, Christian Vöhringer, Oliver Poetz, Jochen M. Schwenk, Nicole Schneiderhan‐Marra, Oliver Pötz, Tim Waterboer, John D. Nieland and Silvia Franceschi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Joos

137 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Joos Germany 33 2.8k 966 966 439 434 139 4.4k
Simon Fredriksson Sweden 25 3.4k 1.2× 348 0.4× 906 0.9× 500 1.1× 353 0.8× 34 5.3k
Jochen M. Schwenk Sweden 33 2.3k 0.8× 840 0.9× 418 0.4× 378 0.9× 203 0.5× 128 3.9k
Sophia Hober Sweden 36 3.3k 1.2× 1.9k 2.0× 394 0.4× 685 1.6× 158 0.4× 151 5.0k
Félix Elortza Spain 31 2.4k 0.8× 226 0.2× 500 0.5× 206 0.5× 347 0.8× 168 3.9k
Peter Waterman United States 24 1.3k 0.5× 461 0.5× 659 0.7× 449 1.0× 406 0.9× 40 4.1k
Koji Yamashita Japan 48 3.6k 1.3× 2.2k 2.3× 276 0.3× 454 1.0× 487 1.1× 277 8.2k
Peter Panizzi United States 24 1.6k 0.6× 403 0.4× 452 0.5× 368 0.8× 508 1.2× 61 4.9k
Peter Hoffmann Australia 41 2.5k 0.9× 197 0.2× 630 0.7× 382 0.9× 261 0.6× 192 5.4k
Anskar Y.H. Leung Hong Kong 33 2.9k 1.0× 620 0.6× 220 0.2× 1.3k 2.9× 358 0.8× 112 5.5k
Takeshi Sano Japan 37 2.1k 0.8× 443 0.5× 499 0.5× 519 1.2× 372 0.9× 177 4.8k

Countries citing papers authored by Thomas Joos

Since Specialization
Citations

This map shows the geographic impact of Thomas Joos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Joos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Joos more than expected).

Fields of papers citing papers by Thomas Joos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Joos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Joos. The network helps show where Thomas Joos may publish in the future.

Co-authorship network of co-authors of Thomas Joos

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Joos. A scholar is included among the top collaborators of Thomas Joos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Joos. Thomas Joos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Milan, Meike Jakobi, Benjamin Röeben, et al.. (2025). Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseases. npj Parkinson s Disease. 11(1). 166–166.
2.
Zimmermann, Milan, Meike Jakobi, Isabel Wurster, et al.. (2024). Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson’s Disease. Journal of Parkinson s Disease. 14(7). 1405–1416. 1 indexed citations
3.
Lerche, Stefanie, Milan Zimmermann, Benjamin Röeben, et al.. (2023). Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD. npj Parkinson s Disease. 9(1). 38–38. 14 indexed citations
4.
Vlasáková, Kateřina, Wendy J. Bailey, Zoltán Erdős, et al.. (2022). Plasma biomarkers TAP, CPA1, and CPA2 for the detection of pancreatic injury in rat: the development of a novel multiplex IA-LC-MS/MS assay and biomarker performance evaluation. Archives of Toxicology. 97(3). 769–785. 3 indexed citations
5.
Schmidt, Felix F., Dajana Lichtenstein, Hannes Planatscher, et al.. (2021). Pesticide mixture effects on liver protein abundance in HepaRG cells. Toxicology. 458. 152839–152839. 8 indexed citations
6.
Yılmaz, Rezzak, Antonio P. Strafella, Alice Bernard, et al.. (2018). Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease. Frontiers in Neurology. 9. 1123–1123. 15 indexed citations
8.
Wegler, Christine, Fabienne Z. Gaugaz, Tommy B. Andersson, et al.. (2016). Protein quantification of human hepatic drug transporters and metabolizing enzymes: an inter-laboratory and methodological comparison. Drug Metabolism Reviews. 48. 98–98. 1 indexed citations
9.
Wurster, Thomas, Oliver Poetz, Konstantinos Stellos, et al.. (2012). Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke. Platelets. 24(7). 560–565. 23 indexed citations
10.
Schneiderhan‐Marra, Nicole, Georg Sauer, Hsin‐Yun Hsu, et al.. (2010). Multiplexed immunoassays for the analysis of breast cancer biopsies. Analytical and Bioanalytical Chemistry. 397(8). 3329–3338. 10 indexed citations
11.
Yu, Xiaobo, Michael Hartmann, Quan Wang, et al.. (2010). µFBI: A Microfluidic Bead-Based Immunoassay for Multiplexed Detection of Proteins from a µL Sample Volume. PLoS ONE. 5(10). e13125–e13125. 24 indexed citations
12.
Yu, Xiaobo, Nicole Schneiderhan‐Marra, Hsin‐Yun Hsu, Jutta Bachmann, & Thomas Joos. (2009). Protein Microarrays: Effective Tools for the Study of Inflammatory Diseases. Methods in molecular biology. 577. 199–214. 21 indexed citations
13.
Weinzierl, Andreas O., Dominik Maurer, Florian Altenberend, et al.. (2008). A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays. Cancer Research. 68(7). 2447–2454. 42 indexed citations
14.
Hartmann, Michael, Johan Roeraade, Dieter Stoll, Markus F. Templin, & Thomas Joos. (2008). Protein microarrays for diagnostic assays. Analytical and Bioanalytical Chemistry. 393(5). 1407–1416. 128 indexed citations
15.
Zahnd, Christian, Emanuel Wyler, Jochen M. Schwenk, et al.. (2007). A Designed Ankyrin Repeat Protein Evolved to Picomolar Affinity to Her2. Journal of Molecular Biology. 369(4). 1015–1028. 191 indexed citations
16.
Joos, Thomas & Jutta Bachmann. (2005). The promise of biomarkers: research and applications. Drug Discovery Today. 10(9). 615–616. 3 indexed citations
17.
Schohl, Anne, Guillermo Barreto, Thomas Joos, & Christine Dreyer. (2002). Oocytes and embryos of Xenopus laevis express two different isoforms of germ cell nuclear factor (GCNF, NR6A1). Mechanisms of Development. 118(1-2). 261–264. 3 indexed citations
18.
Wacker, S., et al.. (2000). Development and Control of Tissue Separation at Gastrulation in Xenopus. Developmental Biology. 224(2). 428–439. 85 indexed citations
19.
Joos, Thomas, et al.. (1998). Cloning of the Xenopus integrin alpha(v) subunit and analysis of its distribution during early development. The International Journal of Developmental Biology. 42(2). 171–179. 11 indexed citations
20.
Joos, Thomas, Charles A. Whittaker, Fanying Meng, et al.. (1995). Integrin α5 during early development of Xenopus laevis. Mechanisms of Development. 50(2-3). 187–199. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026